By using this site, you agree to the Privacy Policy and Terms of Use.

Notification Show More

Home
Automobile
Entertainment
Esports
Food
Health
Life Style
Technology
Travel

Entertainment
Technology

Search

Home
Automobile
Entertainment
Esports
Food
Health
Life Style
Technology
Travel

Have an existing account? Sign In

Follow US

Tag: Nasdaq:AKRO

Akero Therapeutics to Present Preliminary Topline Week 96 Results from Phase 2b SYMMETRY Study Investigating Efruxifermin in Patients with Compensated Cirrhosis (F4) Due to MASH

Akero Therapeutics to Present Preliminary Topline Week 96 Results from Phase 2b SYMMETRY Study Investigating Efruxifermin in Patients with Compensated Cirrhosis (F4) Due to MASH

January 24, 2025 16:05 ET | Source: Akero Therapeutics Inc. Investor webcast…

GlobeNews Wire 27/01/2025

Akero Therapeutics to Present Preliminary Topline Week 96 Results from Phase 2b SYMMETRY Study Investigating Efruxifermin in Patients with Compensated Cirrhosis (F4) Due to MASH

Akero Therapeutics to Present Preliminary Topline Week 96 Results from Phase 2b SYMMETRY Study Investigating Efruxifermin in Patients with Compensated Cirrhosis (F4) Due to MASH

January 24, 2025 16:05 ET | Source: Akero Therapeutics Inc. Investor webcast…

GlobeNews Wire 26/01/2025

Akero Therapeutics to Present Preliminary Topline Week 96 Results from Phase 2b SYMMETRY Study Investigating Efruxifermin in Patients with Compensated Cirrhosis (F4) Due to MASH

Akero Therapeutics to Present Preliminary Topline Week 96 Results from Phase 2b SYMMETRY Study Investigating Efruxifermin in Patients with Compensated Cirrhosis (F4) Due to MASH

January 24, 2025 16:05 ET | Source: Akero Therapeutics Inc. Investor webcast…

GlobeNews Wire 25/01/2025

Akero Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Akero Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference

January 07, 2025 07:00 ET | Source: Akero Therapeutics Inc. SOUTH SAN…

GlobeNews Wire 07/01/2025

Categories

Uncategorized
Health
Technology
Automobile
Esports
Entertainment
Travel
Life Style
Food
News

About US

Through our news networks, we raise millions of users' awareness. We are among the world's most reputable news networks.

Subscribe US

Subscribe to our newsletter to get our newest articles instantly!

Email address:

Leave this field empty if you’re human:

Copyright © 2021 - 2024 AdKhabar. All Rights Reserved. POWERED BY Life Care News.

Welcome Back!

Sign in to your account

Username or Email Address

Password

Remember me

Lost your password?